| Terry J Hill, DO | |
|
901 N Porter Ave, Norman, OK 73071-6404 | |
| (405) 307-1000 | |
| Not Available |
| Full Name | Terry J Hill |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine - Emergency Medical Services |
| Location | 901 N Porter Ave, Norman, Oklahoma |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255327482 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207PE0004X | Emergency Medicine - Emergency Medical Services | 3096 (Oklahoma) | Primary |
| Entity Name | Norman Regional Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912563727 PECOS PAC ID: 2769395185 Enrollment ID: O20031111000299 |
News Archive
A new study from the University of Washington reported obese children are at increased mortality risk in later years following primary liver transplantation (LT).
Significant weight loss can improve the sleep patterns of severely obese people, leading to less daytime sleepiness and better quality of life, a study by the Monash University Centre of Obesity Research and Education has found.
Life Technologies Corporation today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
› Verified 5 days ago
| Entity Name | Emergency Services Of Oklahoma Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215249891 PECOS PAC ID: 8123209012 Enrollment ID: O20110225000085 |
News Archive
A new study from the University of Washington reported obese children are at increased mortality risk in later years following primary liver transplantation (LT).
Significant weight loss can improve the sleep patterns of severely obese people, leading to less daytime sleepiness and better quality of life, a study by the Monash University Centre of Obesity Research and Education has found.
Life Technologies Corporation today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Terry J Hill, DO Po Box 269024, Oklahoma City, OK 73126-9024 Ph: (866) 321-8433 | Terry J Hill, DO 901 N Porter Ave, Norman, OK 73071-6404 Ph: (405) 307-1000 |
News Archive
A new study from the University of Washington reported obese children are at increased mortality risk in later years following primary liver transplantation (LT).
Significant weight loss can improve the sleep patterns of severely obese people, leading to less daytime sleepiness and better quality of life, a study by the Monash University Centre of Obesity Research and Education has found.
Life Technologies Corporation today announced that the company has signed an agreement with Quidel Corporation to distribute and commercialize molecular diagnostic assays for the European market.
Nereus Pharmaceuticals, Inc., a pioneer in drug discovery from marine microbial sources, today announced positive interim results from a randomized Phase 2 clinical trial evaluating the vascular disrupting agent (VDA) plinabulin (NPI-2358) in combination with standard chemotherapy (docetaxel) in patients with advanced non-small cell lung cancer (NSCLC).
One way obese people become salt sensitive and hypertensive has been identified by Medical College of Georgia researchers.
› Verified 5 days ago
Jonathan Wright I, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Attention Physician Residency, Norman, OK 73071 Phone: 405-307-5340 | |
Dr. Olivia Danielle Reed, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 | |
Dr. Spencer Robert Baird, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 706-296-1258 | |
Dr. Dylan Rommel, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1000 | |
Arthur Maduabia, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-5340 | |
Crystal Helena Goree, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1392 | |
Robert Francisco Sanchez, DO Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 901 N Porter Ave, Norman, OK 73071 Phone: 405-307-1392 |